choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • MannKind Diabetes

MannKind Diabetes Newsletter
  • Diabetes Dialogue: Oral GLP-1 Orforglipron in ACHIEVE-1 Trial 24 Apr 2025 15:30 GMT

    … program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care … Company, Novo Nordisk, Sanofi, Abbott Diabetes Care, Dexcom, Medtronic, and … disclosures for Bellini include Abbott Diabetes Care, MannKind, Provention Bio, and …

  • Is MannKind Corp. (NASDAQ:MNKD) the Best Biotech Penny Stock to Buy According to Hedge Funds? 17 Apr 2025 22:51 GMT

    … its inhaled insulin product for diabetes. In Q4 2024, … children with Type 1 diabetes. MannKind anticipates filing for approval … 000 children with Type 1 diabetes. MannKind Corp. (NASDAQ:MNKD) … 3x its current revenue. MannKind estimates that holding just 10% …

  • Diabetes Dialogue: SCORE, Semaglutide, and ACC Wrap-up 16 Apr 2025 20:53 GMT

    … program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care … Company, Novo Nordisk, Sanofi, Abbott Diabetes Care, Dexcom, Medtronic, and … disclosures for Bellini include Abbott Diabetes Care, MannKind, Provention Bio, and …

  • Diabetes Dialogue: Screening for Presymptomatic T1D with Rifka Schulman-Rosenbaum, MD 15 Apr 2025 18:00 GMT

    … program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care … actionable guidance aimed at frontline diabetes care providers. She highlights … disclosures for Bellini include Abbott Diabetes Care, MannKind, Provention Bio, and …

  • Diabetes Dialogue: SOUL and STRIDE Trials from ACC 2025 09 Apr 2025 20:05 GMT

    … program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care … Company, Novo Nordisk, Sanofi, Abbott Diabetes Care, Dexcom, Medtronic, and … disclosures for Bellini include Abbott Diabetes Care, MannKind, Provention Bio, and …

  • The Role of Advanced Technologies in Improving Diabetes Outcomes 07 Apr 2025 23:46 GMT

    … HAGAR, Insulet Corporation, LifeScan, Mannkind Corporation, Roche Diabetes Care, Provention Bio, and … from Fractyl Health, Insulet, MannKind, Tandem Diabetes Care, and Welldoc and … received grants from Dexcom, Mannkind, and Tandem Diabetes Care. Dr McGill …

  • MannKind, JHR Team Up For Long Beach Race 07 Apr 2025 20:16 GMT

    … to raise awareness about diabetes and innovative treatment options, … Mannkind and tell my story living with Type 1 diabetes … is really amazing.” Along with Long Beach this weekend, MannKind … INDYCAR Series schedule. MannKind Corporation focuses on the …

  • MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment Options 07 Apr 2025 16:30 GMT

    … with type 1 diabetes (T1D). MannKind will be a … aligned with MannKind’s approach to treating diabetes. To … Juncos Hollinger Racing. About MannKind MannKind Corporation (Nasdaq: MNKD) … awareness of diabetes and innovative treatment options. MannKind Teams up …

  • Diabetes Dialogue: Updates and News from ATTD 2025 Part 1 04 Apr 2025 21:19 GMT

    … director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care … Advanced Technologies & Treatments for Diabetes (ATTD) 2025 annual conference. … disclosures for Bellini include Abbott Diabetes Care, MannKind, Provention Bio, and …

  • Inhaled insulin lowers HbA1c at 30 weeks in adults with type 1 diabetes 21 Mar 2025 15:40 GMT

    … previously reported, technosphere insulin (Afrezza, MannKind Pharma) resulted in noninferior HbA1c … Advanced Technologies & Treatments for Diabetes, data from the INHALE-3 … Advanced Technologies & Treatments for Diabetes; March 19-22, 2025; Amsterdam …

Satisfied with the content?

Continue to create your account.